• Publications
  • Influence
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Eric J. Bow, Arthur E. Brown, Thierry Calandra, Ronald Feld, Philip A. Pizzo, Kenneth V. I. Rolston, Jerry L. Shenep, and Lowell S. Young St. JudeExpand
  • 1,743
  • 79
Open Access
Principles and Practice of Pediatric Oncology
Principles and practice of pediatric oncology , Principles and practice of pediatric oncology , کتابخانه دیجیتال جندی شاپور اهواز
  • 2,385
  • 62
Open Access
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
PURPOSE To update the 2000 American Society of Clinical Oncology guideline on the use of hematopoietic colony-stimulating factors (CSF). UPDATE METHODOLOGY The Update Committee completed a reviewExpand
  • 1,474
  • 58
Open Access
Management of fever in patients with cancer and treatment-induced neutropenia.
  • P. Pizzo
  • Medicine
  • The New England journal of medicine
  • 6 May 1993
The importance of neutropenia in the risk of serious infection in patients with cancer who are receiving cytotoxic chemotherapy was first recognized nearly 30 years ago1. Since then, considerableExpand
  • 799
  • 31
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.
Abstract Since early diagnosis of even a disseminated fungal infection is difficult and treatment often ineffective in a patient with persistent granulocytopenia, we have prospectively evaluatedExpand
  • 787
  • 18
Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.
Focal hepatosplenic candidiasis has been recognized with increasing frequency in recent years. We reviewed the cases of eight patients seen between 1982 and 1985, and information on 60 patients whoseExpand
  • 353
  • 17
Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever—Reply
To THE EDITOR-In their recent review, Hughes et al. [1] discuss the use of empiric antibiotic therapy for unexplained fever in neutropenic patients. We are concerned about their recommendationsExpand
  • 406
  • 17
Open Access
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.
This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is toExpand
  • 601
  • 11
A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
To assess the efficacy of single-agent therapy relative to standard combination antibiotic therapy for the initial management of fever and neutropenia in cancer patients, we conducted a randomizedExpand
  • 475
  • 9